Ulf Hindorf
Department of Clinical Sciences
Division of Gastroenterology
Faculty of Medicine
Lund University
Sweden
Name/email consistency: high
- Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease. Hindorf, U., Lindqvist, M., Peterson, C., Söderkvist, P., Ström, M., Hjortswang, H., Pousette, A., Almer, S. Gut (2006)
- Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Hindorf, U., Lindqvist, M., Hildebrand, H., Fagerberg, U., Almer, S. Aliment. Pharmacol. Ther. (2006)
- Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Hindorf, U., Lyrenäs, E., Nilsson, A., Schmiegelow, K. Scand. J. Gastroenterol. (2004)
- Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population. Hindorf, U., Peterson, C., Almer, S. Ther. Drug. Monit (2004)